Shuang Cao

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 10

Top Topics

Top Venues

Future medicinal chemistry

OncoTargets and therapy

Drug design, development and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Xiaolan Yuan, Ziwei Liu, Li Wan, Wei Liu, Yan Huang, Shuang Cao
Recent advances in anti-coxsackievirus A16 viral drug research. Future medicinal chemistry 15 (1) (2022)
Yixin Ren, Yongshou Chen, Shuang Cao
Targeted inhibition of the endonuclease activity of influenza polymerase acidic proteins. Future medicinal chemistry 14 (8) (2022)
Xiaolan Yuan, Ziwei Liu, Li Wan, Wei Liu, Yan Huang, Shuang Cao
Recent advances in anti-coxsackievirus A16 viral drug research. Future medicinal chemistry 15 (1) (2022)
Xiaolan Yuan, Ziwei Liu, Li Wan, Wei Liu, Yan Huang, Shuang Cao
Recent advances in anti-coxsackievirus A16 viral drug research. Future medicinal chemistry 15 (1) (2022)
Xiaolan Yuan, Ziwei Liu, Li Wan, Wei Liu, Yan Huang, Shuang Cao
Recent advances in anti-coxsackievirus A16 viral drug research. Future medicinal chemistry 15 (1) (2022)
Xiaolan Yuan, Ziwei Liu, Li Wan, Wei Liu, Yan Huang, Shuang Cao
Recent advances in anti-coxsackievirus A16 viral drug research. Future medicinal chemistry (2022)
Xiaolan Yuan, Ziwei Liu, Li Wan, Wei Liu, Yan Huang, Shuang Cao
Recent advances in anti-coxsackievirus A16 viral drug research. Future medicinal chemistry 15 (1) (2022)
Shuang Cao, Yongshou Chen, Yixin Ren, Yingqi Feng, Sihui Long
GLUT1 biological function and inhibition: research advances. Future medicinal chemistry 13 (14) (2021)
Ying-Qi Feng, Bo-An Li, Fan Feng, Yong-Shou Chen, Yi-Xin Ren, Heng Zhang, Shuang Cao
Novel mTOR Inhibitor Enhances the Sensitivity of Hepatocellular Carcinoma Cells to Molecular Targeting Agents. OncoTargets and therapy 13 (2020)
Ying-Qi Feng, Shuang-Xi Gu, Yong-Shou Chen, Xu-Dong Gao, Yi-Xin Ren, Jian-Chao Chen, Yin-Ying Lu, Heng Zhang, Shuang Cao
Virtual Screening and Optimization of Novel mTOR Inhibitors for Radiosensitization of Hepatocellular Carcinoma. Drug design, development and therapy 14 (2020)